SABCS2012PK1: Richard Gray, Oxford, UK
Channel: Oncoletter
Date: 2012-12-05

ATLAS. 10 v 5 years of adjuvant tamoxifen (TAM) in ER+ disease: Effects on outcome in the first and in the second decade after diagnosis.
Christina Davies, Hongchao Pan, Jon Godwin, Richard Gray, Richard Peto et al.
Pressconference at the San Antonio Breast Cancer Symposium 2012 (Wednesday December 5) produced by oncoletter.org